El.En. S.p.A. (ELN) AI Stock Analysis

4 Followers

El.En. S.p.A.

(Milan:ELN)

Select Model

Rating:67Neutral

Price Target:EUR 17.50▲(5.87% Upside)

Action:reiterated

Date:09/12/26

The score is primarily supported by a strong, conservatively financed balance sheet and improved recent free cash flow. It is held back by 2025 margin compression and currently weak technical momentum signals (negative MACD and low RSI). Valuation is broadly reasonable, providing moderate support but not enough to offset the near-term profitability and momentum concerns.

Positive Factors

Conservative Balance SheetDebt-to-equity of about 0.09, alongside improving debt levels and steadily growing equity, indicates conservative financing. This provides resilience through demand cycles and preserves flexibility to invest in product development, service capacity, or market expansion without relying heavily on borrowing.

Negative Factors

2025 Margin CompressionGross-margin compression and a lower net margin in 2025 show that recent revenue growth has not translated proportionally into profitability. If this pressure persists, it could reduce operating leverage, constrain reinvestment, and weaken the earnings contribution of future sales.

El.En. S.p.A. (ELN) vs. iShares MSCI Italy ETF (EWI)

Market Cap: EUR 1.30B
Dividend Yield: 1.51%
Average Volume (3M): 40.02K
Price to Earnings (P/E): 14.4
Beta (1Y): 0.98
Revenue Growth: 2.55%
EPS Growth: 22.08%
Country: Italy
Employees: 1,441
Sector: General
Sector Strength: 55
Industry: Medical - Devices

El.En. S.p.A. Business Overview & Revenue Model

Company Description

EL.En. S.p.A. is a global leader in the development, manufacturing, marketing, and distribution of advanced laser systems. The company supplies a wide array of medical laser equipment for applications in physiotherapy, orthopedics, traumatology, rheu...

How the Company Makes Money

El.En. makes money mainly by selling laser-based equipment and systems and by providing related services and consumables tied to its installed base. Key revenue streams include: (1) Sales of medical and aesthetic laser devices: revenue generated from...

El.En. S.p.A. Financial Statement Overview

Summary

Financials are solid overall: a strong balance sheet with low and improving leverage (debt-to-equity ~0.09) supports resilience, and revenue expanded over the period with a strong 2025 rebound. Offsetting this, profitability weakened in 2025 (notably gross-margin compression and lower net margin), and cash flow history shows volatility despite improved and positive free cash flow in 2024–2025.

Income Statement

66Positive

Balance Sheet

84Very Positive

Cash Flow

62Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	551.97M	590.85M	565.85M	692.29M	673.58M	571.40M
Gross Profit	185.38M	253.70M	238.80M	252.08M	243.47M	206.09M
EBITDA	107.92M	84.82M	97.35M	83.94M	90.71M	76.59M
Net Income	51.58M	43.41M	51.61M	48.24M	55.11M	45.44M
Balance Sheet
Total Assets	633.37M	627.88M	740.72M	719.21M	735.89M	650.69M
Cash, Cash Equivalents and Short-Term Investments	195.54M	211.44M	157.49M	135.36M	165.13M	182.45M
Total Debt	10.86M	38.07M	46.72M	73.63M	82.92M	60.50M
Total Liabilities	197.77M	200.41M	329.92M	343.75M	379.25M	362.99M
Stockholders Equity	420.17M	411.72M	385.02M	346.03M	313.19M	269.37M
Cash Flow
Free Cash Flow	57.05M	60.08M	73.61M	-1.14M	-16.31M	63.35M
Operating Cash Flow	63.20M	70.81M	83.07M	12.22M	2.12M	79.48M
Investing Cash Flow	1.73M	-12.97M	68.68K	-16.97M	-30.15M	-20.23M
Financing Cash Flow	-8.69M	-30.70M	-47.99M	-24.79M	10.25M	-3.51M

El.En. S.p.A. Technical Analysis

Technical Analysis SentimentPositive

Last Price16.53

Price Trends

50DMA15.91Positive

100DMA15.94Positive

200DMA14.90Positive

Market Momentum

MACD0.12Negative

RSI57.91Neutral

STOCH54.25Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:ELN, the sentiment is Positive. The current price of 16.53 is above the 20-day moving average (MA) of 15.94, above the 50-day MA of 15.91, and above the 200-day MA of 14.90, indicating a bullish trend. The MACD of 0.12 indicates Negative momentum. The RSI at 57.91 is Neutral, neither overbought nor oversold. The STOCH value of 54.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IT:ELN.

El.En. S.p.A. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IT:ELN against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IT:REC	80Outperform	EUR 10.94B	21.58	24.74%	2.55%	8.27%	30.25%
IT:DIA	79Outperform	EUR 4.47B	25.74	13.91%	1.57%	-3.13%	-22.16%
IT:ELN	67Neutral	EUR 1.30B	14.37	17.54%	1.51%	2.55%	22.08%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IT:GPI	52Neutral	EUR 432.06M	26.21	―	4.02%	1.86%	-25.03%

* General Sector Average

Performance Comparison

IT:ELN and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IT:ELN	El.En. S.p.A.	16.53	5.79	53.92%
IT:DIA	DiaSorin S.p.A.	82.64	23.57	39.90%
IT:REC	Recordati Industria Chimica e Farmaceutica SPA	52.45	1.71	3.36%
IT:GHC	Garofalo Health Care S.P.A.	5.36	0.26	5.14%
IT:GPI	GPI SpA	14.94	0.09	0.60%
IT:IMD	I.M.D. International Medical Devices S.P.A.	1.20	-0.18	-13.17%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 12, 2026

El.En. S.p.A. AI Stock Analysis